Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis

Morgan, Celia JA, Freeman, Tom P, Schafer, Gráinne L, Curran, H Valerie·2010·Neuropsychopharmacology
DOI 10.1038/npp.2010.58

Cited by (196)

Items 101–196 of 196

  1. Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
    Tibor Štark, Serena Di Martino, Filippo Drago, Carsten Tobias Wotjak, Vincenzo Micale · 2021 · Pharmacological Research
  2. Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
    Mason M. Silveira, Jonathon Carl Arnold, Steven R. Laviolette, Cecilia J. Hillard, Marta Celorrio, María S. Aymerich, Wendy K. Adams · 2016 · Neuroscience & Biobehavioral Reviews
  3. Effects of cannabidiol in cannabis flower: Implications for harm reduction
    Laurel P. Gibson, Hollis C. Karoly, Jarrod M. Ellingson, Jost Klawitter, Cristina Sempio, Julia E. Squeri, Angela D. Bryan, L. Cinnamon Bidwell, Kent E. Hutchison · 2021 · Addiction Biology
  4. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme
    Chandni Hindocha, Tom P. Freeman, Gráinne Schäfer, Chelsea Gardner, Michael Bloomfield, Elvira Bramon, Celia J. A. Morgan, H. Valerie Curran · 2019 · Addiction Biology
  5. Legal controls on cannabimimetics: An international dilemma?
    Leslie A. King · 2013 · Drug Testing and Analysis
  6. Cannabis use, harms and the management of cannabis use disorder
    Jan Copeland, Nicole Clement, Wendy Swift · 2014 · Neuropsychiatry
  7. Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages
    Daniel J. Kruger, Jessica Sloan Kruger, R. Lorraine Collins · 2020 · Drugs Education Prevention and Policy
  8. Cannabis use in Attention – Deficit/Hyperactivity Disorder (ADHD): A scoping review
    Ana Paula Francisco, Grace Lethbridge, Beth A. Patterson, Carolina Goldman Bergmann, Michael Van Ameringen · 2022 · Journal of Psychiatric Research
  9. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder
    Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha D. C. Shaban, Celia J. A. Morgan, Ali Mofeez, H. Valerie Curran, Tom P. Freeman · 2023 · Translational Psychiatry
  10. Decreased Spontaneous Eye Blink Rates in Chronic Cannabis Users: Evidence for Striatal Cannabinoid-Dopamine Interactions
    Mikael A. Kowal, Lorenza S. Colzato, Bernhard Hommel · 2011 · PLoS ONE
  11. Targeting the Endocannabinoid System in Psychiatric Illness
    Martin A. Katzman, Melissa Furtado, Leena Anand · 2016 · Journal of Clinical Psychopharmacology
  12. Marijuana’s acute effects on cognitive bias for affective and marijuana cues.
    Jane Metrik, Elizabeth R. Aston, Christopher W. Kahler, Damaris J. Rohsenow, John E. McGeary, Valerie S. Knopik · 2015 · Experimental and Clinical Psychopharmacology
  13. Enhancing effects of acute exposure to cannabis smoke on working memory performance
    Shelby L Blaes, Caitlin A. Orsini, H. Holik, Toneisha Stubbs, Shandera N. Ferguson, Sara C. Heshmati, Matthew M. Bruner, Shannon C. Wall, M. Febo, Adriaan W. Bruijnzeel et al. · 2018 · Neurobiology of Learning and Memory
  14. The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity
    Anežka Janatová, Ivo Doskočil, Matěj Božík, Adéla Fraňková, Pavel Tlustoš, Pavel Klouček · 2022 · Chemico-Biological Interactions
  15. Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
    Natalie Ertl, Tom P. Freeman, Claire Mokrysz, Shelan Ofori, Anna Borissova, Kat Petrilli, H. Valerie Curran, Will Lawn, Matthew B. Wall · 2024 · Neuropsychopharmacology
  16. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio
    Victoria G. Zeyl, Kelsey Sawyer, Rachel Wightman · 2020 · Substance Use & Misuse
  17. Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
    Nathan Fearby, Samantha L. Penman, Panayotis K. Thanos · 2022 · International Journal of Environmental Research and Public Health
  18. Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review
    Robin Paul Wilson, Sagnik Bhattacharyya · 2015 · Journal of Psychopharmacology
  19. Individual and combined effects of cannabidiol and Δ 9 -tetrahydrocannabinol on striato-cortical connectivity in the human brain
    Matthew B. Wall, Tom P. Freeman, Chandni Hindocha, Lysia Demetriou, Natalie Ertl, Abigail M. Freeman, A. Jones, Will Lawn, Rebecca Anne Pope, Claire Mokrysz et al. · 2022 · Journal of Psychopharmacology
  20. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study
    Joji Suzuki, Bianca Martin, Sara Prostko, Peter Ray Chai, Roger D. Weiss · 2022 · Integrative Medicine Reports
  21. Δ 9 tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques
    Michael A. Taffe · 2012 · Journal of Psychopharmacology
  22. Pharmacological treatments for drug misuse and dependence
    Kylie Reed, Ed Day, Jenny Keen, John Strang · 2014 · Expert Opinion on Pharmacotherapy
  23. The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers
    Will Lawn, James Hill, Chandni Hindocha, Jocelyn LL Yim, Yumeya Yamamori, Gus Jones, Hannah R Walker, Sebastian F Green, Matthew B. Wall, Oliver David Howes et al. · 2020 · Journal of Psychopharmacology
  24. Attentional bias and treatment adherence in substitute-prescribed opiate users
    Matthew Charles, Chevaughn Wellington, Claire Mokrysz, Tom P. Freeman, Dominic O’Ryan, H. Valerie Curran · 2015 · Addictive Behaviors
  25. The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
    Kelly A. Sagar, Staci A. Gruber · 2025 · CNS Drugs
  26. Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases
    Martin Helcman, Karel Šmejkal · 2021 · Phytochemistry Reviews
  27. Cannabis Addiction and the Brain: a Review
    Amna Zehra, Jamie A. Burns, Christopher Kure Liu, Peter Manza, Corinde E. Wiers, Nora D. Volkow, Gene‐Jack Wang · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
  28. Harm to Others from Substance Use and Abuse: The Underused Potential in Nationwide Registers
    Ingunn Olea Lund, Anne Bukten · 2015 · Substance Abuse Research and Treatment
  29. Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges
    Akeemat O. Tijani, Jivesh Garg, Dorcas Frempong, Gabrielle Verana, Jagroop Kaur, Ramesh Joga, Chetan D Sabanis, Sandeep Kumar, Neeraj Kumar, Ashana Puri · 2022 · Journal of Controlled Release
  30. Adolescent cannabinoid exposure interacts with other risk factors in schizophrenia: A review of the evidence from animal models
    Ariel L. Dunn, Patricia Therese Michie, Deborah M. Hodgson, Lauren R. Harms · 2020 · Neuroscience & Biobehavioral Reviews
  31. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts
    Alberto Sainz-Cort, Daniel F. Jiménez-Garrido, Elena Muñoz Marrón, Raquel Viejo-Sobera, Joost H. Heeroma, José Carlos Bouso · 2021 · Journal of Clinical Psychopharmacology
  32. Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
    Tim Curran, Hélène Devillez, Sophie L. YorkWilliams, L. Cinnamon Bidwell · 2020 · Journal of Cannabis Research
  33. Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?
    Kristine Rømer Thomsen, Birgitte Thylstrup, Emily A. Kenyon, Rachel Lees, Lone Baandrup, Sarah W. Feldstein Ewing, Tom P. Freeman · 2021 · Neuroscience & Biobehavioral Reviews
  34. Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial
    Joji Suzuki, Sara Prostko, Veronica Szpak, Peter Ray Chai, Primavera A. Spagnolo, Ruth E. Tenenbaum, Saeed Ahmed, Roger D. Weiss · 2023 · Frontiers in Psychiatry
  35. A daily diary investigation of cannabis use and its diet and exercise correlates
    Laurel P. Gibson, Carillon J. Skrzynski, G Giordano, Angela D. Bryan · 2023 · Frontiers in Psychology
  36. Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward
    Tom P. Freeman, Ravi Das, Sunjeev K. Kamboj, H. Valerie Curran · 2014 · Social Cognitive and Affective Neuroscience
  37. Whole Organisms or Pure Compounds? Entourage Effect Versus Drug Specificity
    Sidarta Tollendal Gomes Ribeiro · 2018 · Springer eBooks
  38. Limitations to the Dutch cannabis toleration policy
    Margriet van Laar, Peggy van der Pol, Raymond J.M. Niesink · 2016 · International Journal of Drug Policy
  39. A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy
    Ayushe A. Sharma, Rodolphe E. Nenert, Jane B. Allendorfer, Tyler E. Gaston, Leslie E. Grayson, Kathleen A. Hernando, Jerzy P. Szaflarski · 2019 · Epilepsy & Behavior Reports
  40. Tobacco smoking in schizophrenia: investigating the role of incentive salience
    Tom P. Freeman, James M. Stone, Beatriz Orgaz, Louise A Noronha, Stephanie Minchin, H. Valerie Curran · 2013 · Psychological Medicine
  41. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products
    Laurel P. Gibson, Raeghan L. Mueller, Evan A. Winiger, Jost Klawitter, Cristina Sempio, Sarah L. Williams, Angela D. Bryan, L. Cinnamon Bidwell, Kent E. Hutchison · 2022 · Cannabis and Cannabinoid Research
  42. Attention Deficit Hyperactivity Disorder, Cannabis Use, and the Endocannabinoid System: A Scoping Review
    Jennie E. Ryan, Mitchell Fruchtman, Andrea Sparr‐Jaswa, Amy C. Knehans, Brooke K. Worster · 2024 · Developmental Psychobiology
  43. Licensing and regulation of the cannabis market in England and Wales: Towards a cost-benefit analysis
    Stephen E. Pudney, Mark L. Bryan, Emilia DelBono · 2013 · RePEc: Research Papers in Economics
  44. Current Status and Future of Cannabis Research
    Ethan B. Russo, Alice Mead, Dustin Sulak · 2015
  45. Do the effects of cannabis on the hippocampus and striatum increase risk for psychosis?
    Yusuf Daniju, Matthijs Geert Bossong, Karen Rosemarie Brandt, Paul Allen · 2020 · Neuroscience & Biobehavioral Reviews
  46. Potent questions about cannabis and mental health
    Tom P. Freeman · 2015 · The Lancet Psychiatry
  47. Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users.
    Joshua A. Lile, Joseph L. Alcorn, Lon R. Hays, Thomas H. Kelly, William Walton Stoops, Michael J. Wesley, Philip M. Westgate · 2021 · Experimental and Clinical Psychopharmacology
  48. A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’
    Radu Tănăsescu, David J. Rog, Cris S. Constantinescu · 2011 · Expert Opinion on Drug Discovery
  49. Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome
    James R. Lathrop, Sheldon N. Rosen, Margaret McLean Heitkemper, Diana Taibi Buchanan · 2023 · Gastroenterology Nursing
  50. Cannabidiol for the Treatment of Drug Use Disorders
    RAFAEL GUIMARÃES DOS SANTOS, Jaime E. C. Hallak, Antônio Waldo Zuardi, José Alexandre S. Crippa · 2017 · Elsevier eBooks
  51. Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study
    Dominic Oliver, Amir Englund, Edward Chesney, Lucy A. Chester, Jack Wilson, Simina Sovi, Stina Wigroth, John P. Hodsoll, John Strang, Robin M. Murray et al. · 2023 · Addiction
  52. The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study
    Daniel Hall, Will Lawn, Shelan Ofori, Katie Trinci, Anna Borissova, Claire Mokrysz, Kat Petrilli, Michael Bloomfield, Matthew B. Wall, Tom P. Freeman et al. · 2024 · Psychopharmacology
  53. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
    Yasaman Razavi, Fariborz Keyhanfar, Ronak Shabani, Abbas Haghparast, Mehdi Mehdizadeh · 2021 · PubMed Central
  54. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior
    Suhas Ganesh, Jose Cortes-Briones, Ashley M. Schnakenberg Martin, Patrick D. Skosnik, Deepak Cyril D’Souza, Mohini Ranganathan · 2022 · Cannabis and Cannabinoid Research
  55. The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories
    Thomas Snooks, Sherry H. Stewart, Pablo Romero‐Sanchiz, Sarah DeGrace, Sean P. Barrett, Haley C. R. Bernusky, Philip G. Tibbo · 2025 · Pharmacological Research
  56. Cannabidiol for the Treatment of Epilepsy: An Overview of Possible Mechanisms of Action and Preclinical and Human Studies
    RAFAEL GUIMARÃES DOS SANTOS, Jaime E. C. Hallak, Antônio Waldo Zuardi, Ana Chrystina de Souza Crippa, José Alexandre S. Crippa · 2017 · Elsevier eBooks
  57. Cannabis Sativa: uma revisão integrativa dos aspectos legais, toxicológicos e farmacoterapêuticos
    Daniele de Oliveira Cabral Pessoa, Iago Vilar Lira, Lidiany da Paixão Siqueira · 2021 · Research Society and Development
  58. What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland
    Ashely Granville, Jodie Grigg, Michala Kowalski, Eric L. Sevigny, Frank Zobel, Davide Fortin · 2024 · International Journal of Drug Policy
  59. Cannabinoids for the treatment of cannabis abuse disorder
    Andrés Rodríguez, Cynthia Zavala · 2018 · Medwave
  60. Individual and combined effects of Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) on striato-cortical connectivity in the human brain
    Matthew B. Wall, Tom P. Freeman, Chandni Hindocha, Lysia Demetriou, Natalie Ertl, Abigail M. Freeman, A. Jones, Will Lawn, Rebecca Anne Pope, Claire Mokrysz et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Cannabinoid-based Pharmacology for the Management of Substance Use Disorders
    Miguel Ángel Luján, Y. Kim, Linlin Zhang, Joseph F. Cheer · 2024 · Current topics in behavioral neurosciences
  62. Cannabidiol and Cannabis Use Disorder
    María S. García‐Gutiérrez, Francisco Navarrete, Adrián Viudez‐Martínez, Ani Gasparyan, Esther Caparrós, Jorge Manzanares · 2018 · Springer eBooks
  63. Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence
    Jack Wilson, Katherine L. Mills, Matthew Sunderland, Tom P. Freeman, Maree Teesson, Paul Haber, Christina Marel · 2023 · International Journal of Mental Health and Addiction
  64. Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment
    Ya‐Lin Sun, Meenalochani Sivasubramanian, Marija Milenkovic, Andrew B. Gumbert, Jack Bergman, Preston Ge, Myriam Heiman, Marie-Eve Di Raddo, Sarah Louise Withey, Bertha Kalifon Madras et al. · 2025 · Biological Psychiatry Global Open Science
  65. Cannabidiol: de nieuwe haarlemmerolie of een hype?
    Raymond J.M. Niesink, Margriet van Laar · 2012 · Verslaving
  66. Tratamiento de los trastornos psiquiátricos asociados al consumo de cannabis
    F. Árias · 2011 · Trastornos Adictivos
  67. Debut de un ataque de pánico en adolescente de 15 años inducido por consumo de cannabis: abordaje desde la atención primaria
    Germán López-Cortacans, Rosario Pérez García, Albert Pagès Artuñedo · 2015 · FMC - Formación Médica Continuada en Atención Primaria
  68. Efectos del consumo de marihuana en adultos sobre la ingesta y el metabolismo de los nutrientes: una revisión
    Juan Pablo Morales Basto, Elpidia Poveda · 2017 · Revista Española de Nutrición Humana y Dietética
  69. Cannabis, Brain Impact, and Legalization in the United States
    Aaron Anciaux · 2019 · Archives of Medical Research
  70. Pharmacological actions and associated therapeutic levels of phytocannabinoids Addendum 2021
    Jonathon Carl Arnold, David Allsop, Nicholas Lintzeris, Iain S. McGregor · 2016
  71. Epidemiological and biological mechanisms of cannabis as cause of psychosis
    Rebecca Kuepper · 2012
  72. Cannabis en verslaving: feiten en misverstanden
    Raymond J.M. Niesink, Margriet van Laar · 2010 · Verslaving
  73. Design and synthesis of novel cannabinergic analogs with controlled detoxification
    Rishi Sharma · 2011
  74. A VET AOD Training Enhancement Project Cannabis Makes the Grade A resource to support the development of a 'cannabis competent' workforce in the AOD sector
    Michael White, ANN M. ROCHE, Allan Trifonoff, Etty Matalon, Kathryn Elkins · 2014
  75. Análise de canabinóides e cocaínicos em amostras de cabelo e sua correlação com sintomas psiquiátricos
    Marcela Nogueira Rabelo Alves · 2015
  76. The acute cognitive, psychological and electrophysiological effects of cannabis constituents
    Amir Englund · 2015
  77. Aplicação de agonistas canabinoides na terapêutica e o seu impacto sociopolítico-económico
    Gordhandas, Chandini · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  78. Cannabis Use and Attention-Deficit/Hyperactivity Disorder: Potential Moderators
    Kristin E. Maple, Natasha E. Wright, Krista M. Lisdahl · 2017 · Elsevier eBooks
  79. Drug and non-drug reward processing in cigarette and cannabis users
    Will Lawn · 2016 · UCL Discovery (University College London)
  80. Cannabinoid Transmission in the Basolateral Amygdala Modulates Prefrontal Cortex and Ventral Hippocampal Activity
    Brian J.G. Pereira · 2018 · Scholarship@Western (Western University)
  81. The Efficacy of Cannabidiol in Mitigating Delta-9-Tetrahydrocannabinol-induced Harms: A Systematic Review
    de Freitas, Lauren Alyson · 2020
  82. Efectos del consumo de Omegas 6 y 3 sobre los niveles de ácido araquidónico y su asociación con la adicción a la comida en adultos obesos: Un estudio piloto
    Morales Basto, Juan Pablo · 2020
  83. Role of Cannabinoids in Pain Management
    Ethan B. Russo, Andrea G. Hohmann · 2014 · Springer eBooks
  84. Drug use in Australia: A public health approach
    Andrew Smirnov, Jake Moses Najman · 2022 · Cambridge University Press eBooks
  85. Public health issues and special populations
    2022 · Cambridge University Press eBooks
  86. Cannabidiol: Overview, Complexities, and Opportunities for Behavioral Health
    Susan R.B. Weiss, Katia Delrahim Howlett · 2022 · Psychiatry update
  87. Consenso colombiano del tratamiento con cannabidiol (CBD) puro en psiquiatría
    Carlos Arturo Cassiani-Miranda, César Augusto Arango-Dávila, Jeffrey S. Gonzalez, Mario D. Parra-Vera, Jorge Téllez-Vargas, Lilian Rocío Morales-Puerto · 2023 · Revista Colombiana de Psiquiatría
  88. Categorization of Marijuana Suspected Policies’ Seizures in Southeast Serbia According to Cannabinoids Content
    E. Kostić, Mirjana M. Djukic, Aleksandra Antović, Miodrag Zdravković, Miroslav Milić, Ivan Stojanovic, Stevan Todorović, Maja Vujović · 2023 · Separations
  89. Chronic cannabis use and the brain: a neurophysiological investigation into the effects on human memory and attention
    Robert A. Battisti · 2010 · Research Online (University of Wollongong)
  90. The Endocannabinoid System and Medicinal Cannabis
    Kylie O’Brien, Carolyn Bosak · 2025 · Springer eBooks
  91. CANNABINOIDS IN CHRONIC PAIN MANAGEMENT: EFFICACY, SAFETY, AND THE CONTROVERSIES SURROUNDING MEDICAL MARIJUANA – A REVIEW OF CURRENT EVIDENCE
    Szymon Szabelski, Adam Solarz, Joanna Kryślak, Maciej Sokołowski, Karolina Oskroba · 2025 · International Journal of Innovative Technologies in Social Science
  92. Cannabinoids as a Systemic Modulator of Homeostasis: Modern Biochemical Mechanisms of Action and Clinical Perspectives
    I. SORVILLO, A. S. VOITKIVSKA, M.-A. T. VACHKO, A. M. ZHELIZKO, Ю.М. Федевич · 2026 · Experimental and Clinical Physiology and Biochemistry
  93. Cannabis
    George F. Koob, Michael A. Arends, Mandy L. McCracken, Michel Le Moal · 2026 · Elsevier eBooks
  94. Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles
    Yasuhiro Kishi, Ichiro Takumi, Kakusho Chigusa Nakajima‐Ohyama · 2026 · Psychiatry and Clinical Neurosciences Reports
  95. Impact of Cannabis (Marijuana) on Nicotine Metabolism in U.S. Adults Who Smoke Cigarettes: Findings from NHANES 2013–2018
    Wanyu Hua, Philip Lazarus, Tolulope V. Adebile, Joshua E. Muscat · 2026 · Cannabis and Cannabinoid Research
  96. Salience attribution in addiction and psychosis
    Tom P. Freeman · 2013 · UCL Discovery (University College London)